Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis

NCT06521762 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT06521762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06521762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Withdrawn
Start date
January 31, 2026
Completion date
January 31, 2029
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune checkpoint inhibitor-related diarrhea and colitis